A high-throughput screening approach to discover potential colorectal cancer chemotherapeutics: Repurposing drugs to disrupt 14-3-3 protein-BAD interactions
S. He, L. Delgadillo Silva, G. A. Rutter, G. E. Lim
This paper uses a BRET-based high-throughput screen to identify FDA-approved drugs that disrupt 14-3-3{zeta}BAD interactions, showing potential for colorectal cancer treatment.
bioRxiv · Dec 14, 2023 · PreprintCancer Biology